Izotropic Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.2181
- Today's High:
- $0.2181
- Open Price:
- $0.2181
- 52W Low:
- $0.112
- 52W High:
- $0.638
- Prev. Close:
- $0.181
- Volume:
- 1702
Company Statistics
- Market Cap.:
- $10.39 million
- Book Value:
- -0.039
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $-52502
- Profit Margin:
- 0%
- Return on Assets TTM:
- -297.64%
- Return on Equity TTM:
- -37440.35%
Company Profile
Izotropic Corporation had its IPO on under the ticker symbol IZOZF.
The company operates in the Healthcare sector and Diagnostics & Research industry. Izotropic Corporation has a staff strength of 0 employees.
Stock update
Shares of Izotropic Corporation opened at $0.22 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.22 - $0.22, and closed at $0.22.
This is a +20.5% increase from the previous day's closing price.
A total volume of 1,702 shares were traded at the close of the day’s session.
In the last one week, shares of Izotropic Corporation have increased by +9.05%.
Izotropic Corporation's Key Ratios
Izotropic Corporation has a market cap of $10.39 million, indicating a price to book ratio of 115.8079 and a price to sales ratio of 0.
In the last 12-months Izotropic Corporation’s revenue was $0 with a gross profit of $-52502 and an EBITDA of $-5647132. The EBITDA ratio measures Izotropic Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Izotropic Corporation’s operating margin was 0% while its return on assets stood at -297.64% with a return of equity of -37440.35%.
In Q0.33333333333333, Izotropic Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Izotropic Corporation’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Izotropic Corporation’s profitability.
Izotropic Corporation stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -4.22. Its price to sales ratio in the trailing 12-months stood at 0.
Izotropic Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $442113.00
- Total Liabilities
- $3.46 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $6393
- Dividend Payout Ratio
- 0%
Izotropic Corporation ended 2024 with $442113.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $442113.00 while shareholder equity stood at $-3073759.00.
Izotropic Corporation ended 2024 with $0 in deferred long-term liabilities, $3.46 million in other current liabilities, in common stock, $-18092050.00 in retained earnings and $0 in goodwill. Its cash balance stood at $165685.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Izotropic Corporation’s total current assets stands at $317344.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.15 million and inventory worth $0.
In 2024, Izotropic Corporation's operating cash flow was $0 while its capital expenditure stood at $6393.
Comparatively, Izotropic Corporation paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.22
- 52-Week High
- $0.638
- 52-Week Low
- $0.112
- Analyst Target Price
- $
Izotropic Corporation stock is currently trading at $0.22 per share. It touched a 52-week high of $0.638 and a 52-week low of $0.638. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.19 and 200-day moving average was $0.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 1136.3% of the company’s stock are held by insiders while 0.3% are held by institutions.
Frequently Asked Questions About Izotropic Corporation
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.